Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance

Kate Mounsey, Deborah Holt, James McCarthy, Bart Currie, Shelley Walton

Research output: Contribution to journalArticlepeer-review

91 Citations (Scopus)

Abstract

Limited effective treatments, coupled with recent observations of emerging drug resistance to oral ivermectin and 5% permethrin, raise concerns regarding the future control of scabies, especially in severe cases and in endemic areas where repeated community treatment programs are in place. There is consequently an urgent need to define molecular mechanisms of drug resistance in scabies mites and to develop and assess alternative therapeutic options, such as tea tree oil, in the event of increasing treatment failure. Molecular studies on scabies mites have, until recently, been restricted; however; recent advances are providing new insights into scabies mite biology and genetic mechanisms underlying drug resistance. These may assist in overcoming many of the current difficulties in monitoring treatment efficacy and allow the development of more sensitive tools for monitoring emerging resistance. � 2008 Future Medicine Ltd.
Original languageEnglish
Pages (from-to)57-66
Number of pages10
JournalFuture Microbiology
Volume3
Issue number1
Publication statusPublished - 2008

Fingerprint

Dive into the research topics of 'Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance'. Together they form a unique fingerprint.

Cite this